|
| contact. |
 |
|
Erik Kinnman Vice President, Chief Strategic Officer and Head of Investor Relations & Public Affairs E-mail
+46 8 697 20 00 |
 |
|
 |
| 
Our business goal is to create a long-term profitable pharmaceutical company through international launch and sales of in-house developed specialist pharmaceuticals that gives people a better life.
A well-founded growth strategy has largely already been implemented:
- Expand product portfolio and geographic spread
- Focus on specialist indications
- Fully develop and use biotech expertise
|
 |
 |
|